Literature DB >> 16702372

Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.

Elizabeth E Brown1, Daniele Fallin, Ingo Ruczinski, Amy Hutchinson, Brian Staats, Francesco Vitale, Carmela Lauria, Diego Serraino, Giovanni Rezza, Georgina Mbisa, Denise Whitby, Angelo Messina, James J Goedert, Stephen J Chanock.   

Abstract

Classic Kaposi sarcoma (CKS) is an inflammatory-mediated neoplasm primarily caused by Kaposi sarcoma-associated herpesvirus (KSHV). Kaposi sarcoma lesions are characterized, in part, by the presence of proinflammatory cytokines and growth factors thought to regulate KSHV replication and CKS pathogenesis. Using genomic DNA extracted from 133 CKS cases and 172 KSHV-latent nuclear antigen-positive, population-based controls in Italy without HIV infection, we examined the risk of CKS associated with 28 common genetic variants in 14 immune-modulating genes. Haplotypes were estimated for IL1A, IL1B, IL4, IL8, IL8RB, IL10, IL12A, IL13, and TNF. Compared with controls, CKS risk was decreased with 1235T/-1010G-containing diplotypes of IL8RB (odds ratio, 0.49; 95% confidence interval, 0.30-0.78; P = 0.003), whereas risk was increased with diplotypes of IL13 containing the promoter region variant 98A (rs20541, alias +130; odds ratio, 1.88; 95% confidence interval, 1.15-3.08; P = 0.01) when considered in multivariate analysis. Risk estimates did not substantially vary by age, sex, incident disease, or disease burden. Our data provide preliminary evidence for variants in immune-modulating genes that could influence the risk of CKS. Among KSHV-seropositive Italians, CKS risk was associated with diplotypes of IL8RB and IL13, supporting laboratory evidence of immune-mediated pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702372     DOI: 10.1158/1055-9965.EPI-05-0791

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

Review 1.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Authors:  Andrzej Roszak; Adrianna Mostowska; Anna Sowińska; Margarita Lianeri; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2012-05-22       Impact factor: 3.201

3.  A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma.

Authors:  Peter V Aka; Troy J Kemp; Charles S Rabkin; Meredith S Shiels; Mark N Polizzotto; Carmela Lauria; Francesco Vitale; Ligia A Pinto; James J Goedert
Journal:  J Infect Dis       Date:  2014-08-22       Impact factor: 5.226

4.  EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.

Authors:  Melissa J Blumenthal; Charlotte Schutz; Graeme Meintjes; Zainab Mohamed; Marc Mendelson; Jon M Ambler; Denise Whitby; Romel D Mackelprang; Sinead Carse; Arieh A Katz; Georgia Schäfer
Journal:  Cancer Epidemiol       Date:  2018-08-31       Impact factor: 2.984

5.  A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection.

Authors:  Vincent Pedergnana; Antoine Gessain; Patricia Tortevoye; Minji Byun; Delphine Bacq-Daian; Anne Boland; Jean-Laurent Casanova; Laurent Abel; Sabine Plancoulaine
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

6.  Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily.

Authors:  Lesley A Anderson; Carmela Lauria; Nino Romano; Elizabeth E Brown; Denise Whitby; Barry I Graubard; Yan Li; Angelo Messina; Lorenzo Gafà; Francesco Vitale; James J Goedert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

7.  Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection.

Authors:  Helen Byakwaga; Arturo Barbachano-Guerrero; Dongliang Wang; Shane McAllister; Kamal Naphri; Miriam Laker-Oketta; Conrad Muzoora; Peter W Hunt; Jeffrey Martin; Christine A King
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

8.  Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily.

Authors:  James J Goedert; Giuseppe Calamusa; Carmelo Dazzi; Anna Perna; Colleen Pelser; Lesley A Anderson; Camille Madsen; Liliana R Preiss; Matt Airola; Barry I Graubard; Angelo Messina; Carmela Lauria; Nino Romano
Journal:  Infect Agent Cancer       Date:  2010-12-02       Impact factor: 2.965

9.  Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007.

Authors:  Simon B Zeichner; Ana L Ruiz; Gabriel P Suciu; Rachel Lerner Zeichner; Estelamari Rodriguez
Journal:  ISRN Oncol       Date:  2012-12-25

10.  Nationwide registry-based analysis of cancer clustering detects strong familial occurrence of Kaposi sarcoma.

Authors:  Eevi Kaasinen; Mervi Aavikko; Pia Vahteristo; Toni Patama; Yilong Li; Silva Saarinen; Outi Kilpivaara; Esa Pitkänen; Paul Knekt; Maarit Laaksonen; Miia Artama; Rainer Lehtonen; Lauri A Aaltonen; Eero Pukkala
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.